Hansen et al. already showed that MHC-E CD8+ T cells were essential to protect against SIV in SIV-infected RMs, but future studies are needed to assess the contribution of HLA-E-restricted T cell responses in TB to confirm its efficacy as a primary target [20,37]. The gene discussed is CD8A; the disease is tuberculosis.